InSure® ONE™ is a fecal immunochemical test (FIT). It is a highly accurate test for detecting blood in stool, which may be an indication of lower gastrointestinal bleeding associated with disorders such as diverticulitis, ulcerative colitis, polyps, colorectal cancer or large adenomas that bleed.
The American Cancer Society (ACS) recommends both men and women at average risk for developing colorectal cancer (CRC) beginning screening at age 45. Read more here.
(2) A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. Cole et al. Journal of Medical Screening 2003